Schattner A, Sokolovskaya N, Cohen J
Department of Medicine, Kaplan Medical Center, Rehovot, Israel.
J Intern Med. 2000 Jan;247(1):153-5. doi: 10.1046/j.1365-2796.2000.00612.x.
A healthy 70-year-old woman who took nimesulide for 5 days, presented 2 weeks later with jaundice for which no other cause was found. Laboratory evidence of coagulopathy, hypoalbuminaemia and hypoglycaemia were present on admission, and liver biopsy showed massive necrosis of hepatocytes and severe inflammatory infiltrate. Despite supportive and corticosteroid treatment, her jaundice deepened and progressive acute renal failure developed, characterized by a 'prerenal' profile changing into irreversible acute tubular necrosis pattern, coma, occult Gram-negative sepsis and death. Although rare, nimesulide-associated hepatotoxicity and nephrotoxicity may occur and should be recognized as early as possible, to ensure immediate drug withdrawal and treatment.
一名健康的70岁女性服用尼美舒利5天后,两周后出现黄疸,未发现其他病因。入院时存在凝血功能障碍、低白蛋白血症和低血糖的实验室证据,肝脏活检显示肝细胞大片坏死和严重炎症浸润。尽管进行了支持性治疗和使用了皮质类固醇,但她的黄疸加深,出现了进行性急性肾衰竭,其特征是“肾前性”特征转变为不可逆的急性肾小管坏死模式、昏迷、隐匿性革兰氏阴性菌败血症并最终死亡。尽管罕见,但尼美舒利相关的肝毒性和肾毒性可能会发生,应尽早识别,以确保立即停药和治疗。